Pfizer wins in Canadian appeals court |
|
|
|
Published
:
Mon, 30 Apr 2007 22:40
|
NEW YORK (AP) - Pfizer Inc. said Monday a Canadian appeals court blocked release in that country of generic Celebrex by Novopharm, the Canadian unit of Israeli-based Teva Pharmaceutical Industries Ltd.The ruling by the Federal Court of Appeal of Canada reverses a prior Canadian court ruling and prohibits the sale of a generic version of Pfizer's anti-inflammatory painkiller until its patent expires in 2014.Novopharm could appeal the decision to Canada's Supreme Court.It isn't the first time Pfizer has prevailed in Canadian courts. In December, a court blocked Novopharm's efforts to sell Canadians a generic version of Pfizer's Lipitor, the cholesterol-reducing medication.Shares of Pfizer rose 4 cents to $26.50 in after-hours trading and ended the day 15 cents lower at $26.46 on the New York Stock Exchange. U.S.-traded shares of Teva fell 70 cents to close at $38.31 on the Nasdaq Stock Market.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Appeals court reverses patent ruling 